Daglozin 10mg Tablet

Daglozin 10mg Tablet contains the active ingredient Dapagliflozin, which belongs to the class of sodium-glucose cotransporter 2 (SGLT2) inhibitors. It is prescribed for the management of type 2 diabetes mellitus in adults. Dapagliflozin works by inhibiting the reabsorption of glucose in the kidneys, leading to increased glucose excretion in the urine and lowering blood sugar levels.

Uses:

Daglozin 10mg Tablet is used to improve glycemic control in adults with type 2 diabetes mellitus. It is typically prescribed as part of a comprehensive treatment plan that includes diet, exercise, and other antidiabetic medications. By reducing blood sugar levels, Dapagliflozin helps to decrease the risk of diabetes-related complications such as cardiovascular disease, kidney disease, and nerve damage.

Dosage:

The dosage of Daglozin 10mg Tablet is determined by the healthcare provider based on factors such as the patient’s medical history, renal function, and response to treatment. It is usually taken orally once daily, with or without food. The tablet should be swallowed whole with a glass of water and should not be crushed or chewed. Patients should follow the prescribed dosage and administration instructions carefully.

Side Effects:

Common side effects associated with Daglozin 10mg Tablet may include urinary tract infections, genital yeast infections, increased urination, thirst, dizziness, nausea, diarrhea, and fatigue. These side effects are usually mild and transient. In some cases, more serious side effects such as hypoglycemia (low blood sugar), ketoacidosis, or allergic reactions may occur. Patients should report any adverse reactions to their healthcare provider promptly.

Precautions:

Before using Daglozin 10mg Tablet, patients should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. This medication may interact with other drugs, so it’s essential to review the patient’s medication regimen to avoid potential interactions. Patients with impaired renal function or a history of ketoacidosis should use Daglozin with caution.

When Not to Use:

Daglozin 10mg Tablet is contraindicated in patients with a known hypersensitivity to Dapagliflozin or any other components of the medication. It should not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis. Patients with severe renal impairment, end-stage renal disease, or a history of lactic acidosis should also avoid this medication.